All Stories

  1. Towards Standardization of CGM Performance Studies: The QUSS-CGM Questionnaire for Assessing User Satisfaction
  2. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2025
  3. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  4. Response to Comments on Freckmann et al. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. Diabetes Care 2025;48:1213–1217
  5. Discrepancies between current displayed and auto‐logged glucose values in FreeStyle Libre 3: Implications for clinical interpretation
  6. The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
  7. Comparator Value Pairing Impacts Reported Continuous Glucose Monitoring System Accuracy
  8. Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring Systems
  9. Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM
  10. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems
  11. Compliance With FDA iCGM Special Controls is Dependent on Study Design and Procedures
  12. Calibration and performance of a Raman-based device for non-invasive glucose monitoring in type 2 diabetes
  13. Feasibility of a Glucose Manipulation Procedure for the Standardized Performance Evaluation of Continuous Glucose Monitoring Systems
  14. Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes
  15. Performance of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
  16. The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring
  17. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2024
  18. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  19. Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings
  20. The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
  21. An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin
  22. Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia
  23. Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring
  24. Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes
  25. Unlocking Potential: Personalized Lifestyle Therapy for Type 2 Diabetes Through a Predictive Algorithm-Driven Digital Therapeutic
  26. Point-of-care testing: state-of-the art and perspectives
  27. Ein Pilotversuch zu Smartwatches mit Glukosemessfunktion
  28. Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems
  29. Effect of Arterialization on Venous Blood Glucose Concentrations and Implications for Observed Continuous Glucose Monitoring Accuracy
  30. Quality assessment of glucose measurement with regard to epidemiology and clinical management of diabetes mellitus in Germany
  31. Correction: Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
  32. A Critical Discussion of Alert Evaluations in the Context of Continuous Glucose Monitoring System Performance
  33. Benefits of Usability Evaluation in the Development Process of Diabetes Technologies Using the Example of a Continuous Glucose Monitoring System Prototype
  34. A Proposal for the Clinical Characterization of Continuous Glucose Monitoring Trend Arrow Accuracy
  35. Even Head-to-Head Comparison Studies of Continuous Glucose Monitoring System Performance Can be Biased
  36. Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
  37. Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes
  38. Investigation of the Effect of 70 Potential Interferents on Measurement Results of Two Blood Glucose Monitoring Systems
  39. Are You Using the Recommended Test Tubes for Glucose Measurement? New Guidelines for Pre-analytical Handling in Germany
  40. Plasma Glucose Concentrations in Different Sampling Tubes Measured on Different Glucose Analysers
  41. Head-to-Head Evaluation of Continuous Glucose Monitoring and Automated Insulin Delivery Systems: Why are They not Used More Systematically?
  42. Evaluation of System Accuracy, Precision, Hematocrit Influence, and User Performance of Two Blood Glucose Monitoring Systems Based on ISO 15197:2013/EN ISO 15197:2015
  43. Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: A Narrative Review of Challenges and Proposed Solutions
  44. Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial
  45. Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting
  46. Güte der Glukosemessung in niedergelassenen diabetologischen Praxen basierend auf einer Strukturbefragung
  47. Kommentar zu den Konsequenzen aus der „Befragung zur Güte der Glukosemessung in niedergelassenen diabetologischen Praxen basierend auf einer Strukturbefragung“
  48. Comment on Hochfellner et al. Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106
  49. Evaluation of the Tolerability of a Steel Needle and an Adhesive for a Patch Pump
  50. Differences in venous, capillary and interstitial glucose concentrations in individuals without diabetes after glucose load
  51. Glucose measurement and control in patients with type 1 or type 2 diabetes
  52. Automatisierte Insulindosierung: Ideale Diabeteskontrolle mit vielen offenen Fragen
  53. Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy
  54. A Statistical Approach for Assessing the Compliance of Integrated Continuous Glucose Monitoring Systems with Food and Drug Administration Accuracy Requirements
  55. Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
  56. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial
  57. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022
  58. User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results
  59. Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems
  60. Improving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration
  61. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022
  62. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  63. Suitability of continuous glucose monitoring in healthy subjects to detect effects of meal sequences and nutritional content of meals on postprandial glycemic responses
  64. Real-Time Continuous Glucose Monitoring Can Predict Severe Hypoglycemia in People with Type 1 Diabetes: Combined Analysis of the HypoDE and DIAMOND Trials
  65. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions
  66. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  67. Accuracy Evaluation of a Novel Reusable Patch Pump Prototype
  68. Patch Pumps: What are the advantages for people with diabetes?
  69. Patch Pumps: Periodic Insulin Delivery Patterns
  70. Definition, Classification and Diagnosis of Diabetes Mellitus
  71. Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
  72. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  73. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  74. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
  75. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  76. Impact of Blood Glucose Monitoring System Accuracy on Clinical Decision Making for Diabetes Management
  77. Evaluation of the Accuracy and Reliability of a Tubeless Insulin Infusion System Under Laboratory Conditions
  78. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021
  79. Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
  80. Correction to: Diabetes Technol Ther 2021;23(5):350−357
  81. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021
  82. Response to Seibold: Data Obtained With Early Generations of CGM Sensors: Comment on Pleus et al.
  83. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany
  84. Glukosemessung in der Diabetesdiagnostik und -therapie: Laboratoriumsmedizinische Untersuchung inkl. patientennaher Sofortdiagnostik, Blutglukoseselbstmessung und kontinuierliches Glukosemonitoring
  85. Entwicklung und psychometrische Evaluation eines herstellerunabhängigen Wissenstests zum kontinuierlichen Glukosemonitoring in Echtzeit für insulinbehandelte Menschen mit Diabetes
  86. Development and Psychometric Assessment of a Manufacturer Independent Knowledge Questionnaire on Real Time Continuous Glucose Monitoring for insulin-treated People with Diabetes
  87. Comment on “Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory” by Spanou and Makris
  88. Evaluation of Meal Carbohydrate Counting Errors in Patients with Type 1 Diabetes
  89. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020
  90. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
  91. Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
  92. Standardization process of continuous glucose monitoring: Traceability and performance
  93. Mean Absolute Relative Difference of Blood Glucose Monitoring Systems and Relationship to ISO 15197
  94. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation
  95. Diabetesdiagnostik in der Hausarztpraxis
  96. Methoden der Stoffwechselkontrolle – HbA1c versus „time in range“
  97. Variation of Mean Absolute Relative Differences of Continuous Glucose Monitoring Systems Throughout the Day
  98. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  99. Evaluation of Trueness and Precision of a Bench-Top Laboratory Glucose Analyzer Using Reference Materials
  100. Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges
  101. Evaluation of the SPECTRUM training programme for real‐time continuous glucose monitoring: A real‐world multicentre prospective study in 120 adults with type 1 diabetes
  102. Diabetesdiagnostik in der Praxis
  103. Diabetesdiagnostik in der Hausarztpraxis
  104. Diagnostik des Gestationsdiabetes mellitus in der Praxis
  105. Stability of Glucose Concentrations in Frozen Plasma
  106. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control
  107. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020
  108. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  109. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
  110. Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems
  111. Proof of Concept for a New Raman-Based Prototype for Noninvasive Glucose Monitoring
  112. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  113. Der Auftragsverarbeitungsvertrag (AV-Vertrag): Relevanz und praktische Bedeutung für die Diabetologie
  114. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score
  115. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics
  116. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies
  117. Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management
  118. The YSI 2300 Analyzer Replacement Meeting Report
  119. Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose
  120. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
  121. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents
  122. Basics and use of continuous glucose monitoring (CGM) in diabetes therapy
  123. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015
  124. Simple Strategies for Retrospective Detection of Meals in Diabetes Datasets
  125. Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System
  126. Definition, Classification and Diagnosis of Diabetes Mellitus
  127. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  128. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
  129. Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature
  130. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  131. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  132. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia
  133. Concept and Implementation of a Novel Patch Pump for Insulin Delivery
  134. Untersuchung der Messgenauigkeit verschiedener Blutglukosemesssysteme, erworben in Discountern und Drogeriemärkten im Rahmen der Versorgungsforschung in Anlehnung an ISO 15197
  135. Feasibility of Fully Closed Loop Insulin Delivery in Type 2 Diabetes
  136. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  137. Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space
  138. 119-LB: Bolus Dosing Accuracy of Two Recent Insulin Pumps
  139. 279-OR: How to Use rtCGM Data to Predict Future Severe Hypoglycemia?
  140. Advanced carbohydrate counting: An engineering perspective
  141. Deviation Analysis and Interval Modeling as Complementary Tools to Evaluate Insulin Dosing Algorithms in Diabetes
  142. Entwicklung und teststatistische Prüfung eines Wissenstests zum rtCGM (real-time continuous glucose monitoring): „rtCGM-Profi-Check“
  143. Genauigkeit verschiedener Insulinpumpen bei der Abgabe von Basalraten unter Verwendung eines typischen zirkadianen Profils mit zusätzlichen Bolusabgaben
  144. Kontinuierliches Glukosemonitoring bei Menschen ohne Diabetes nach vordefinierten Mahlzeiten und im Alltag
  145. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
  146. Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study
  147. Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements
  148. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  149. Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison
  150. The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study
  151. Comment on �accuracy and precision of four main glucometers used in a sub-Saharan African country: a cross-sectional study� by Choukem et al
  152. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  153. Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197
  154. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  155. Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
  156. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  157. Reporting Insulin Pump Accuracy: Trumpet Curves According to IEC 60601-2-24 and Beyond
  158. Evaluation of Analytical Performance of Three Blood Glucose Monitoring Systems: System Accuracy, Measurement Repeatability, and Intermediate Measurement Precision
  159. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  160. Erratum: Definition, Klassifikation und Diagnostik des Diabetes mellitus
  161. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  162. Correction: Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  163. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  164. Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  165. Patch Pumps: Are They All the Same?
  166. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose MonitoringParts of the data have previously been presented at the 77th Scientific Sessions of the American Diabetes Association in San...
  167. Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring SystemsParts of these data were previously presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes, September 11–15, 2017, Lis...
  168. Accuracy of five systems for self-monitoring of blood glucose in the hands of adult lay-users and professionals applying ISO 15197:2013 accuracy criteria and potential insulin dosing errors
  169. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps
  170. First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
  171. Definition, Classification and Diagnosis of Diabetes Mellitus
  172. Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany
  173. Definition, classification and diagnostics of diabetes mellitus
  174. Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
  175. Evaluation of Hematocrit Influence on Measurements With a Novel Self-Monitoring of Blood Glucose System Based on ISO 15197:2013
  176. Basal Rate Delivery of Different Insulin Pumps—An Accuracy Evaluation
  177. Delivery of Low Basal Rates in Different Insulin Pumps—An Accuracy Evaluation
  178. Predictors of Hypoglycemia Avoidance in a Randomized Controlled rtCGM Trial (HypoDE)
  179. The Relationship between A1C and Hypoglycemia in the HypoDE Study
  180. Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit Influence
  181. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
  182. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors
  183. HbA1c-Messung in Deutschland: Ist die Qualität ausreichend für Verlaufskontrolle und Diagnose?
  184. Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published
  185. System Accuracy and User Performance Evaluation of an Improved System for Self-Monitoring of Blood Glucose
  186. Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
  187. Identification of Mixed-Meal Effects on Insulin Needs and Glycemic Control
  188. Impact of Carbohydrate Counting Errors on Glycemic Control in Type 1 Diabetes
  189. People with Type 1 Diabetes and Increased Hypoglycemia Frequency have a Higher Risk for Nocturnal Hypoglycemia During the Second Half of the Night
  190. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates
  191. HbA1c-POC-Systeme zur Therapiekontrolle und Diagnostik des Diabetes: Ausreichende Qualität und Qualitätskontrolle?
  192. Flash Glucose Monitoring: Differences Between Intermittently Scanned and Continuously Stored Data
  193. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  194. Praxisempfehlung der DDG: Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  195. Accuracy Evaluation of a New System for Self-Monitoring of Blood Glucose With Three Test Strip Lots Based on ISO 15197:2013
  196. Comparative Handling Analysis of Different Insulin Pump Systems
  197. Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study
  198. ISO 15197: 2013 Evaluation of a Blood Glucose Monitoring System’s Measurement Accuracy
  199. Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors
  200. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View
  201. Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
  202. Introduction of a Novel Smartphone-Coupled Blood Glucose Monitoring System
  203. Strengths and Limitations of New Approaches for Graphical Presentation of Blood Glucose Monitoring System Accuracy Data
  204. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel Based on ISO 15197 Requirements
  205. Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block
  206. Accuracy Assessment of an Improved Version of an Established Blood Glucose Monitoring System for Self-Testing Following ISO 15197:2013
  207. Continuous glucose monitoring: A training programme for all age groups
  208. Bolus Calculator Safety Mandates a Need for Standards
  209. Regulatorische Defizite bei Medizinprodukten
  210. Accuracy and user performance evaluation as key factors in self-monitoring in diabetes patients
  211. Significance and Reliability of MARD for the Accuracy of CGM Systems
  212. Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind
  213. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life
  214. Deviation analysis of clinical studies as tool to tune and assess performance of diabetes control algorithms
  215. SPECTRUM
  216. Boluses in Insulin Therapy
  217. Interferences and Limitations in Blood Glucose Self-Testing
  218. Comment on “The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System” by Bailey et al.
  219. Performance of two updated blood glucose monitoring systems: an evaluation following ISO 15197:2013
  220. Continuous Glucose Monitoring in 2015
  221. Self-Monitoring of Blood Glucose
  222. Identification of CGM Time Delays and Implications for BG Control in T1DM
  223. Positionspapier der Kommission für Labordiagnostik in der Diabetologie der DGKL und der DDG
  224. Can We Use Measurements to Classify Patients Suffering from Type 1 Diabetes into Subcategories and Does It Make Sense?
  225. Accuracy of BG Meters and CGM Systems: Possible Influence Factors for the Glucose Prediction Based on Tissue Glucose Concentrations
  226. The Rectangle Target Plot
  227. Accuracy Evaluation of an Integrated Blood Glucose Monitoring System With Improved Test Cassettes Following ISO 15197:2013
  228. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing(POCT)-Blutglukose-Messsystemen mit Unit-use-Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestati...
  229. Updated Requirements for Measurement Quality and Quality Assurance of Point-Of-Care Testing (POCT) – Blood Glucose Measurement Systems with Unit-Use Reagents Suitable for the Initial Diagnosis of Diabetes Manifested in Pregnancy or Gestational Diabetes...
  230. CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring
  231. Performance Comparison of CGM Systems
  232. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in Unaltered Blood Samples in the Low Glycemic Range and Blood Samples in the Concentration Range Defined by ISO 15197
  233. System Accuracy Evaluation of Different Blood Glucose Monitoring Systems Following ISO 15197:2013 by Using Two Different Comparison Methods
  234. Time Delay of CGM Sensors
  235. Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View
  236. Identification of diurnal patterns in insulin action from measured CGM data for patients with T1DM
  237. Diagnostik des Gestationsdiabetes: Die Crux liegt bei der Blutentnahme
  238. ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose
  239. Neue Technologien in der Diabetologie
  240. System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method
  241. Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy
  242. Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings
  243. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)
  244. Quality of HbA1c Measurement in the Practice
  245. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing (POCT)-Blutglukose-Messsystemen mit Unit-use Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestat...
  246. Performance assessment of estimation methods for CIR/ISF in bolus calculators∗∗This work has been supported by the Linz Center of Mechatronics (LCM) in the framework of the Austrian COMET-K2 program
  247. LMI-based online estimation of a time-varying time-delay in continuous glucose measurement devices
  248. Use of Microdialysis-Based Continuous Glucose Monitoring to Drive Real-Time Semi-Closed-Loop Insulin Infusion
  249. Self-Monitoring of Blood Glucose
  250. Accuracy Assessment of an Advanced Blood Glucose Monitoring System for Self-Testing With Three Reagent System Lots Following ISO 15197:2013
  251. Model of the glucose-insulin system of type-1 diabetics and optimization-based bolus calculation
  252. Short-term prediction of blood glucose concentration using interval probabilistic models
  253. Accuracy Assessment of Two Novel Systems for Self-Monitoring of Blood Glucose Following ISO 15197:2013
  254. Accuracy Evaluation of Three Systems for Self-monitoring of Blood Glucose With Three Different Test Strip Lots Following ISO 15197
  255. Impact of Partial Pressure of Oxygen in Blood Samples on the Performance of Systems for Self-Monitoring of Blood Glucose
  256. Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility
  257. A-/B-Blutzuckermesssysteme
  258. Konsequenzen der Genauigkeit von Blutglucosemesssystemen
  259. Diabetestechnologie
  260. Auf dem Weg zum „Closed-loop“-System
  261. System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems
  262. Influence of Partial Pressure of Oxygen in Blood Samples on Measurement Performance in Glucose-Oxidase-Based Systems for Self-Monitoring of Blood Glucose
  263. Partial Pressure of Oxygen in Capillary Blood Samples from the Fingertip
  264. In Response to Teodorczyk and Coauthors: System Accuracy of Blood Glucose Monitoring Devices According to the Current and Proposed ISO 15197 Standards
  265. Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms
  266. System Accuracy of Blood Glucose Monitoring Systems: Impact of Use by Patients and Ambient Conditions
  267. Performance Evaluation of a Continuous Glucose Monitoring System under Conditions Similar to Daily Life
  268. Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring
  269. Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel
  270. Effect of Infusion Rate and Indwelling Time on Tissue Resistance Pressure in Small-Volume Subcutaneous Infusion like in Continuous Subcutaneous Insulin Infusion
  271. Considerations for an Institution for Evaluation of Diabetes Technology Devices to Improve Their Quality in the European Union
  272. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use
  273. System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197
  274. Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197
  275. Increasing Local Blood Flow by Warming the Application Site: Beneficial Effects on Postprandial Glycemic Excursions
  276. Feasibility of Overnight Closed-Loop Control Based on Hourly Blood Glucose Measurements
  277. Integrated Self-Monitoring of Blood Glucose System: Handling Step Analysis
  278. Accuracy in Blood Glucose Measurement: What Will a Tightening of Requirements Yield?
  279. Clinical Performance of a Device That Applies Local Heat to the Insulin Infusion Site: A Crossover Study
  280. Blutzuckermessgeräte
  281. Clinical Performance of Three Bolus Calculators in Subjects with Type 1 Diabetes Mellitus: A Head-to-Head-to-Head Comparison
  282. System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
  283. Experimentelle Untersuchungen und klinische Evidenz der Insulinpumpentherapie (CSII)
  284. Glucose monitoring by microdialysis: performance in a multicentre study
  285. The Clinical Research Tool: A High-Performance Microdialysis-Based System for Reliably Measuring Interstitial Fluid Glucose Concentration
  286. The Circadian Study:: The Get-Up Phenomenon in Type 1 Diabetes
  287. Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals
  288. Recent advances in continuous glucose monitoring